A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice

Hepatology

Volumn 31, Issue 1, 2000, Pages 173-181

  Brown, Jennifer J ^a   Parashar, Bhupesh ^a   Moshage, Han ^a   Tanaka, Kathryn E ^b   Engelhardt, Dean ^c   Rabbani, Elazar ^c   Roy Chowdhury, Namita ^a,b   Roy Chowdhury, Jayanta ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Enzon Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL IMMORTALIZATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER BIOPSY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; VIREMIA; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 0033960043     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310126     Document Type: Article

References (15)

1. Hess G, Reuschling M. Toward routine diagnosis of hepatitis B virus DMA. Clinical Biochemistry 1993;26:289-293.
2. .London W and Evans A. The epidemiology of hepatitis viruses B, C and D. Clinics in Laboratory Medicine 1996;16:251-271.
3. Rothstein KD, Munoz SJ. Interferon and other therapies for Hepatitis B virus and Hepatitis C virus infections. Clinics in Laboratory Medicine 1996;16:465-491.
4. McKenzie R, Fried MW, Sallie R, Conjeevaram H, DiBisceglie AM, Park Y, Savarese B, et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), and investigational nucleoside analoque for chronic hepatitis B. N Engl J Med 1995;333:1099-1105.
5. Rensen P, Van Dijk M, Havenaar E, Busterbosch M, Kruijt J, Van Berkel T. Selective liver targetting of antivirals by recombinant chylomicrons. Nature Medicine 1995;1:221-225.
6. Shouval D, Chakraborty P, Ruiz-Opazo N, Baum S, Spigland I, Muchmore E, Gerber MA, et al. Chronic hepatitis in chimpanzee carriers of hepatitis B virus;morphologic, immunologic and viral DNA studies. Proc Natl Acad Sci USA 1980;77:6147-6151.
7. Walter E, Keist R, Niederost B, Pult I, Blum HE. Hepatitis B virus infection of Tupaia hepatocytes in vitro and in vivo. HEPATOLOGY 1996;24:1-5.
8. Van RQ, Su JJ, Huang DR, Can YC, Yang C, Huang GH. Human hepatitis B virus and hepatocellular carcinoma 1. Experimental infection of tree shrews with hepatitis B virus. J Cancer Res Clin Oncol 1996;122:283-288.
9. Yan RQ, Su JJ, Huang DR, Can YC, Yang C, Huang GH. Human hepatitis B virus and hepatocellular carcinoma II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1. J Cancer Res Clin Oncol 1996;122:289-295.
10. Brown JJ, Parashar B, Kadakol A, Rabbani E, Engelhardt D, Roy-Chowdhury J. Serological and pathomorphological characterization of human hepatitis B virus in a small primate, Tupaia belangeri. HEPATOLOGY 1998;28(Suppl):927S.
11. Offensperger WB, Blum HE, Gerok W. Molecular therapeutic strategies in hepatitis B virus infection. Clinical Investigator 1994;72:737-741.
12. Korba BA, Xie H, Wright KN, Hornbickly WE, Gerin JL, Tennant BC, Hosteller KL. Liver-targetted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus ddG in woodchuck hepatitis virus infeciton in vivo. HEPATOLOGY 23:958-963.
13. Mandart E, Kay A, Galibert E Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human HBV sequences. J. Virol 1984;49:782-792.
14. Seeger C, Ganem D, Varmus HE. Biochemical and Genetic Evidence for the Hepatitis B virus replication strategy. Science 1986;232:477-484.
15. Chisari E Hepatitis B Virus Transgenic Mice: models of Viral Immunobiology and Pathogenesis. Current Topics in Microbiology and Immunology 1996;206:149-173.